Solésence To Report Second Quarter 2025 Financial Results and Host a Conference Call
Solésence (Nasdaq: SLSN), a leader in scientifically-driven healthcare solutions for beauty and life science categories, has scheduled its second quarter 2025 financial results announcement for Thursday, July 31, 2025, after market close.
The company will host a conference call and webcast on the same day at 4:00 p.m. CDT (5:00 p.m. EDT). The call will feature presentations from President & CEO Jess Jankowski and COO Kevin Cureton. Participants can access the event through the company's investor relations website or register for dial-in access.
Solésence (Nasdaq: SLSN), leader nelle soluzioni sanitarie scientificamente avanzate per i settori della bellezza e delle scienze della vita, ha programmato la comunicazione dei risultati finanziari del secondo trimestre 2025 per giovedì 31 luglio 2025, dopo la chiusura del mercato.
La società terrà una conference call e una webcast lo stesso giorno alle 16:00 CDT (17:00 EDT). La chiamata includerà presentazioni del Presidente e CEO Jess Jankowski e del COO Kevin Cureton. I partecipanti potranno accedere all'evento tramite il sito web delle relazioni con gli investitori della società o registrarsi per ottenere l'accesso telefonico.
Solésence (Nasdaq: SLSN), líder en soluciones sanitarias basadas en la ciencia para las categorías de belleza y ciencias de la vida, ha programado el anuncio de resultados financieros del segundo trimestre de 2025 para el jueves 31 de julio de 2025, después del cierre del mercado.
La compañía realizará una llamada conferencia y una transmisión en vivo ese mismo día a las 4:00 p.m. CDT (5:00 p.m. EDT). La llamada contará con presentaciones del presidente y CEO Jess Jankowski y del COO Kevin Cureton. Los participantes podrán acceder al evento a través del sitio web de relaciones con inversionistas de la empresa o registrarse para obtener acceso por llamada.
솔레센스(Nasdaq: SLSN)는 뷰티 및 생명과학 분야를 위한 과학 기반 헬스케어 솔루션의 선두주자로서, 2025년 2분기 재무실적 발표를 2025년 7월 31일 목요일 장 마감 후로 예정했습니다.
회사는 같은 날 오후 4시 CDT(오후 5시 EDT)에 컨퍼런스 콜과 웹캐스트를 개최합니다. 이번 콜에서는 사장 겸 CEO 제스 잰코프스키와 COO 케빈 큐어튼이 발표를 진행할 예정입니다. 참가자들은 회사의 투자자 관계 웹사이트를 통해 행사에 접속하거나 전화 접속 등록을 할 수 있습니다.
Solésence (Nasdaq : SLSN), leader dans les solutions de santé basées sur la science pour les secteurs de la beauté et des sciences de la vie, a programmé l'annonce des résultats financiers du deuxième trimestre 2025 pour le jeudi 31 juillet 2025, après la clôture du marché.
L'entreprise organisera une conférence téléphonique et une webdiffusion le même jour à 16h00 CDT (17h00 EDT). L'appel comprendra des présentations du Président-directeur général Jess Jankowski et du Directeur des opérations Kevin Cureton. Les participants pourront accéder à l'événement via le site des relations investisseurs de la société ou s'inscrire pour obtenir un accès par téléphone.
Solésence (Nasdaq: SLSN), ein führender Anbieter wissenschaftlich fundierter Gesundheitslösungen für die Bereiche Schönheit und Lebenswissenschaften, hat die Veröffentlichung der Finanzergebnisse für das zweite Quartal 2025 für Donnerstag, den 31. Juli 2025, nach Börsenschluss angekündigt.
Das Unternehmen wird am selben Tag um 16:00 Uhr CDT (17:00 Uhr EDT) eine Telefonkonferenz und Webcast veranstalten. Die Präsentationen werden vom Präsidenten & CEO Jess Jankowski sowie dem COO Kevin Cureton gehalten. Teilnehmer können über die Investor-Relations-Website des Unternehmens teilnehmen oder sich für einen Telefonzugang registrieren.
- None.
- None.
ROMEOVILLE, Ill., July 24, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced that the Company will report results for the second quarter of 2025 after the market close on Thursday, July 31, 2025, and host a conference call and webcast on the same date.
Second Quarter 2025 Conference Call Details
Date / Time: Thursday, July 31, 2025 - 4:00 p.m. CDT, 5:00 p.m. EDT
Speakers: Jess Jankowski, President & CEO, and Kevin Cureton, Chief Operating Officer
Webcast Link: https://edge.media-server.com/mmc/p/7n5uumgk
Dial-In Link: https://register-conf.media-server.com/register/BI09c7b8c2d77f48ae92fcc4fbdbcd785a
To receive the dial-in number, as well as your personalized PIN, you must register at the above link. Once registered, you will also have the option to have the system dial-out to you once the conference call begins. If you forget your PIN prior to the conference call, you can simply re-register.
The call may also be accessed through the company’s investor relations website, at https://ir.solesence.com/. Please join the conference call at least five minutes before prior to the start time.
About Solésence, Inc.
Solésence, Inc. (Nasdaq: SLSN) is a leader in scientifically-driven health care solutions across beauty and life science categories. With a mission to deliver joy through innovation, inclusivity and the science of beautiful skin, we have redefined mineral-based sun protection by maximizing transparency, effectiveness, aesthetics, and wearability — empowering individuals to embrace beauty on their own terms. Combining best-in-class skin health solutions with the celebration of self-care, we allow brands to deliver unique product claims and attributes by seamlessly integrating protection, prevention, and treatment technologies into daily use products. Learn more at solesence.com.
Media Contact:
Investor Relations Contact:
FAQ
When will Solésence (SLSN) report Q2 2025 earnings?
What time is the Solésence Q2 2025 earnings call?
Who will speak at Solésence's Q2 2025 earnings call?
How can I access Solésence's Q2 2025 earnings call?
